The autism spectrum or autistic spectrum describes a range of conditions classified as neurodevelopmental disorders in the fifth revision of the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders 5th edition (DSM-5). The DSM-5, published in 2013, redefined the autism spectrum to encompass the previous (DSM-IV-TR) diagnoses of autism, Asperger syndrome, pervasive developmental disorder not otherwise specified (PDD-NOS), childhood disintegrative disorder, and Rett syndrome. These disorders are characterized by social deficits and communication difficulties, stereotyped or repetitive behaviors and interests, sensory issues, and in some cases, cognitive delays.
- 1 Classification
- 2 Characteristics
- 3 Causes
- 4 Pathophysiology
- 5 Diagnosis
- 6 Management
- 7 Epidemiology
- 8 History
- 9 Schools
- 10 Autism rights movement
- 11 See also
- 12 References
- 13 External links
A revision to autism spectrum disorder (ASD) was proposed in the Diagnostic and Statistical Manual of Mental Disorders version 5 (DSM-5), released May 2013. The new diagnosis encompasses previous diagnoses of autistic disorder, Asperger's disorder, childhood disintegrative disorder, and PDD-NOS. Rather than categorizing these diagnoses, the DSM-5 will adopt a dimensional approach to diagnosing disorders that fall underneath the autism spectrum umbrella. It is thought that individuals with ASDs are best represented as a single diagnostic category because they demonstrate similar types of symptoms and are better differentiated by clinical specifiers (i.e., dimensions of severity) and associated features (i.e., known genetic disorders, epilepsy and intellectual disability). An additional change to the DSM includes collapsing social and communication deficits into one domain. Thus, an individual with an ASD diagnosis will be described in terms of severity of social communication symptoms, severity of fixated or restricted behaviors or interests and associated features. The restriction of onset age has also been loosened from 3 years of age to "early developmental period", with a note that symptoms may manifest later when demands exceed capabilities.
Autism forms the core of the autism spectrum disorders. Asperger syndrome is closest to autism in signs and likely causes; unlike autism, people with Asperger syndrome have no significant delay in language development. PDD-NOS is diagnosed when the criteria are not met for a more specific disorder. Some sources also include Rett syndrome and childhood disintegrative disorder, which share several signs with autism but may have unrelated causes; other sources differentiate them from ASD, but group all of the above conditions into the pervasive developmental disorders.
The terminology of autism can be bewildering. Autism, Asperger syndrome, and PDD-NOS are sometimes called the autistic disorders instead of ASD, whereas autism itself is often called autistic disorder, childhood autism, or infantile autism. Although the older term pervasive developmental disorder and the newer term autism spectrum disorder largely or entirely overlap, the former was intended to describe a specific set of diagnostic labels, whereas the latter refers to a postulated spectrum disorder linking various conditions. ASD, in turn, is a subset of the broader autism phenotype (BAP), which describes individuals who may not have ASD but do have autistic-like traits, such as avoiding eye contact.
Under DSM-IV-TR, autism was characterized by delays or abnormal functioning before the age of three years in one or more of the following domains: (1) social interaction; (2) communication; and (3) restricted, repetitive, and stereotyped patterns of behavior, interests, and activities. There is also a unique form of autism called autistic savantism, where a child can actually display outstanding skills in music, art, and numbers with no practice. (National Institute of Health. U.S. Food and Drug Administration. CDC. Alan G Weintraub, MD May 12, 2013)
Asperger syndrome was distinguished from autism by the lack of delay or deviance in early language development. Additionally, individuals with Asperger syndrome did not have significant cognitive delays.
Although autism spectrum disorders are thought to follow two possible developmental courses, most parents report that symptom onset occurred within the first year of life. One course of development follows a gradual course of onset in which parents report concerns in development over the first two years of life and diagnosis is made around 3–4 years of age. Some of the early signs of ASDs in this course include decreased looking at faces, failure to turn when name is called, failure to show interests by showing or pointing, and delayed pretend play. A second course of development is characterized by normal or near-normal development followed by loss of skills or regression in the first 2–3 years. Regression may occur in a variety of domains, including communication, social, cognitive, and self-help skills; however, the most common regression is loss of language. There continues to be a debate over the differential outcomes based on these two developmental courses. Some studies suggest that regression is associated with poorer outcomes and others report no differences between those with early gradual onset and those who experience a regression period. Overall, the prognosis is poor for persons with classical (Kanner-type) autism with respect to academic achievement and poor to below-average for persons across the autism spectrum with respect to independent living abilities; in each case, a lack of early intervention exacerbates the odds against success. However, many individuals show improvements as they grow older. The two best predictors of favorable outcome in autism are the absence of intellectual disability and the development of some communicative speech prior to five years of age. Overall, the literature stresses the importance of early intervention in achieving positive longitudinal outcomes.
While a specific cause or specific causes of autism spectrum disorders has yet to be found, many risk factors have been identified in the research literature that may contribute to the development of an ASD. These risk factors include genetics, prenatal and perinatal factors, neuroanatomical abnormalities, and environmental factors. It is possible to identify general risk factors, but much more difficult to pinpoint specific factors. In the current state of knowledge, prediction can only be of a global nature and therefore requires the use of general markers.
Genetic risk factors
The results of family and twin studies suggest that genetic factors play a role in the etiology of autism and other pervasive developmental disorders. Studies have consistently found that the prevalence of autism in siblings of autistic children is approximately 15 to 30 times greater than the rate in the general population. In addition, research suggests that there is a much higher concordance rate among monozygotic twins compared to dizygotic twins. It appears that there is no single gene that can account for autism. Instead, there seem to be multiple genes involved, each of which is a risk factor for part of the autism syndrome through various groups.
- Intellectual disability
- Seizures and epilepsy
- Tuberous sclerosis
- Fragile X syndrome
- Chromosome 15q11-q13 interstal duplication, du/triplications
- Chromosome 15q11-q13 deletions (i.e. Angelman syndrome and Prader-Willi syndrome)
- Rett syndrome
- Smith-Lemli-Opitz syndrome, a cholesterol biosynthesis disorder
Prenatal and perinatal risk factors
A number of prenatal and perinatal complications have been reported as possible risk factors for autism. These risk factors include maternal gestational diabetes, maternal and paternal age over 30, bleeding after first trimester, use of prescription medication (e.g. valproate) during pregnancy, and meconium in the amniotic fluid. While research is not conclusive on the relation of these factors to autism, each of these factors has been identified more frequently in autistic children compared to their non-autistic siblings and other normally developing youth.
Perhaps the most controversial claim regarding autism etiology was the "vaccine controversy". This conjecture, arising from a case of scientific misconduct, suggested that autism results from brain damage caused either by (1) the measles, mumps, rubella (MMR) vaccine itself, or by (2) thimerosal, a vaccine preservative. No convincing scientific evidence supports these claims, based on various lines of evidence including the observation that the rate of autism continues to climb despite elimination of thimerosal from routine childhood vaccines. A 2014 meta-analysis examined ten major studies on autism and vaccines involving 1.25 million children worldwide; it concluded that neither the MMR vaccine nor the vaccine components thimerosal or mercury lead to the development of ASDs.
In general, neuroanatomical studies support the notion that autism is linked to a combination of brain enlargement in some areas and brain reduction in other areas. These studies suggest that autism may be caused by abnormal neuronal growth and pruning during the early stages of prenatal and postnatal brain development, leaving some areas of the brain with too many neurons and other areas with too few neurons. Some research has reported an overall brain enlargement in autism while others suggest abnormalities in several areas of the brain, including the frontal lobe, the mirror neuron system, the limbic system, the temporal lobe, and the corpus callosum.
In neuroanatomical studies, when performing Theory of Mind and facial emotion response tasks, the median person on the autism spectrum exhibits less activation in the primary and secondary somato-sensory cortices than does the median member of a properly sampled control population. This discrepancy is consistent with reports of abnormal patterns of cortical thickness and grey matter volume in those regions of autistic persons' brains.
Mirror neuron system
The mirror neuron system (MNS) consists of a network of brain areas that have been associated with empathy processes in humans. In humans, the MNS has been identified in the inferior frontal gyrus (IFG) and the inferior parietal lobule (IPL) and is thought to be activated during imitation or observation of behaviors. It has been proposed that problems with the mirror neuron system may underlie autism; however the connection between mirror neuron dysfunction and autism is tentative and it remains to be seen how mirror neurons may be related to many of the important characteristics of autism.
Functions of the temporal lobe are related to many of the deficits observed in individuals with ASDs, such as receptive language, social cognition, joint attention, action observation, and empathy. The temporal lobe also contains the superior temporal sulcus (STS) and the fusiform face area (FFA), which may mediate facial processing. It has been argued that dysfunction in the STS underlies the social deficits that characterize autism. Compared to typically developing individuals, one fMRI study found that individuals with high-functioning autism had reduced activity in the FFA when viewing pictures of faces.
It has been noted that children with ASD are afflicted with undiagnosed comorbid conditions such as abnormalities in the peripheral nervous, immune, gastrointestinal and energy production systems, suggesting that ASD isn't strictly a central nervous system (CNS) disorder, but rather a systemic one. It has been hypothesized that ASD could be linked to a mitochondrial disorder, as it is a basic cellular abnormality that has the potential to cause disturbances in a wide range of body systems. A recent meta-analysis study, as well as other population studies have shown that approximately 5% of children with ASD meet the criteria for classical mitochondrial disease (MD), and that around 7.2 percent of children with ASD present with some variant of mitochondrial dysfunction. It is currently unclear why the mitochondrial dysfunction occurs considering that only 23% of children with both ASD and MD present with mitochondrial DNA (mtDNA) abnormalities.
ASD can be detected as early as eighteen months or even younger in some cases. A reliable diagnosis can usually be made by the age of two. The diverse expressions of ASD symptoms pose diagnostic challenges to clinicians. Individuals with an ASD may present at various times of development (e.g., toddler, child, or adolescent) and symptom expression may vary over the course of development. Furthermore, clinicians are required to differentiate among the different pervasive developmental disorders as well as other disorders such as intellectual disability not associated with a pervasive developmental disorder, specific developmental disorders (e.g. language), and early onset schizophrenia, as well as the social-cognitive deficits caused by brain damage from alcohol abuse.
Considering the unique challenges associated with diagnosing ASD, specific practice parameters for the assessment of ASD have been published by the American Academy of Neurology, the American Academy of Child and Adolescent Psychiatry, and a consensus panel with representation from various professional societies. The practice parameters outlined by these societies include an initial screening of children by general practitioners (i.e., "Level 1 screening") and for children who fail the initial screening, a comprehensive diagnostic assessment by experienced clinicians (i.e. "Level 2 evaluation"). Furthermore, it has been suggested that assessments of children with suspected ASD be evaluated within a developmental framework, include multiple informants (e.g., parents and teachers) from diverse contexts (e.g., home and school), and employ a multidisciplinary team of professionals (e.g., clinical psychologists, neuropsychologists, and psychiatrists).
After a child fails an initial screening, psychologists administer various psychological assessment tools to assess for ASD. Amongst these measurements, the Autism Diagnostic Interview-Revised (ADI-R) and the Autism Diagnostic Observation Schedule (ADOS) are considered the "gold standards" for assessing autistic children. The ADI-R is a semi-structured parent interview that probes for symptoms of autism by evaluating a child's current behavior and developmental history. The ADOS is a semistructured interactive evaluation of ASD symptoms that is used to measure social and communication abilities by eliciting a number of opportunities (or "presses") for spontaneous behaviors (e.g., eye contact) in standardized context. Various other questionnaires (e.g., The Childhood Autism Rating Scale) and tests of cognitive functioning (e.g., The Peabody Picture Vocabulary Test) are typically included in an ASD assessment battery.
Autism spectrum disorders tend to be highly comorbid with other disorders. Comorbidity may increase with age and may worsen the course of youth with ASDs and make intervention/treatment more difficult. Distinguishing between ASDs and other diagnoses can be challenging because the traits of ASDs often overlap with symptoms of other disorders and the characteristics of ASDs make traditional diagnostic procedures difficult.
The most common medical condition occurring in individuals with autism spectrum disorders is seizure disorder or 
Intellectual disabilities are some of the most common comorbid disorders with ASDs. Recent estimates suggest that 40-69% of individuals with ASD have some degree of mental retardation, with females more likely to be in severe range of mental retardation. Learning disabilities are also highly comorbid in individuals with an ASD. Approximately 25-75% of individuals with an ASD also have some degree of learning disability.
A variety of anxiety disorders tend to co-occur with autism spectrum disorders, with overall comorbidity rates of 7-84%. Rates of comorbid depression in individuals with an ASD range from 4–58%.
Deficits in ASD are often linked to behavior problems, such as difficulties following directions, being cooperative, and doing things on other people's terms. Attention Deficit Hyperactivity Disorder (ADHD)-like symptoms are seen to be part of the ASD diagnosis.
There is no known cure for autism. The main goals of treatment are to lessen associated deficits and family distress, and to increase quality of life and functional independence. No single treatment is best and treatment is typically tailored to the child's needs. Intensive, sustained special education programs and behavior therapy early in life can help children acquire self-care, social, and job skills. Available approaches include applied behavior analysis (ABA), developmental models, structured teaching, speech and language therapy, social skills therapy, and occupational therapy. There has been increasing attention to the development of evidenced-based interventions for young children with ASDs. Unresearched alternative therapies have also been implemented (for example, vitamin therapy and acupuncture). Although evidenced-based interventions for autistic children vary in their methods, many adopt a psychoeducational approach to enhancing cognitive, communication and social skills while minimizing problem behaviors. It has been argued that no single treatment is best and treatment is typically tailored to the child's needs.
One of the most empirically supported intervention approaches is applied behavioral analysis, particularly in regard to early intensive home-based therapy. Although ABA therapy has a strong research base, other studies have found that this approach may be limited by diagnostic severity and IQ.
Reviews tend to estimate a prevalence of 6 per 1,000 for autism spectrum disorders as a whole, however prevalence rates vary for each of the developmental disorders in the spectrum. Autism prevalence has been estimated at 1-2 per 1,000, Asperger syndrome at roughly 0.6 per 1,000, childhood disintegrative disorder at 0.02 per 1,000, and PDD-NOS at 3.7 per 1,000. These rates are consistent across cultures and ethnic groups, as autism is considered a universal disorder.
While rates of autism spectrum disorders are consistent across cultures, they vary greatly by gender, with boys being affected far more frequently than girls. The average male-to-female ratio for ASDs is 4.2:1, affecting 1 in 70 males, but only 1 in 315 females. Females, however, are more likely to have associated cognitive impairment. Among those with an ASD and intellectual disability, the sex ratio may be closer to 2:1. Prevalence differences might be accounted by gender differences in the expression of clinical symptoms, with females showing less atypical behaviors and, therefore, less likely to receive an ASD diagnosis.
Controversies have surrounded various claims regarding the etiology of autism spectrum disorders. In the 1950s, the "refrigerator mother theory" emerged as an explanation for autism. The hypothesis was based on the idea that autistic behaviors stem from the emotional frigidity, lack of warmth, and cold, distant, rejecting demeanor of a child's mother. Naturally, parents of children with an autism spectrum disorder suffered from blame, guilt, and self-doubt, especially as the theory was embraced by the medical establishment and went largely unchallenged into the mid-1960s. While the "refrigerator mother theory" has been rejected in the research literature, its effects have lingered into the 21st century. Another controversial claim suggests that watching extensive amounts of television may cause autism. This hypothesis was largely based on research suggesting that the increasing rates of autism in the 1970s and 1980s were linked to the growth of cable television at this time. This conjecture has not been supported in the research literature.
There are a number of schools for students on the autism spectrum.
Autism rights movement
The autism rights movement (ARM) is a social movement within the neurodiversity movement that encourages autistic people, their caregivers and society to adopt a position of neurodiversity, accepting autism as a variation in functioning rather than a mental disorder to be cured. The ARM advocates a variety of goals including a greater acceptance of autistic behaviors; therapies that teach autistic individuals coping skills rather than therapies focused on imitating behaviors of neurotypical peers; the creation of social networks and events that allow autistic people to socialize on their own terms; and the recognition of the Autistic community as a minority group.
Autism rights or neurodiversity advocates believe that the autism spectrum is genetic and should be accepted as a natural expression of the human genome. This perspective is distinct from two other likewise distinct views: (1) the mainstream perspective that autism is caused by a genetic defect and should be addressed by targeting the autism gene(s) and (2) the perspective that autism is caused by environmental factors like vaccines and pollution and could be cured by addressing environmental causes.
The movement is controversial. There are a wide variety of both supportive and critical opinions about the movement among people who are autistic or associated with autistic people. A common criticism leveled against autistic activists is that the majority of them are high-functioning or have Asperger syndrome and do not represent the views of all autistic people., even though some prominent figures in the movement (such as Amy Sequenzia) are nonverbal and have been labeled as low-functioning.
- Autism and memory
- Autism and working memory
- Asperger syndrome and neuroscience
- Global perceptions of autism
- Lorna Wing
- Hans Asperger
- "Autism spectrum disorder fact sheet". DSM5.org. American Psychiatric Publishing. 2013. Retrieved October 13, 2103.
- "Home | APA DSM-5". Dsm5.org. Retrieved 2012-02-21.
- Lord C, Cook EH, Leventhal BL, Amaral DG. Autism spectrum disorders. Neuron. 2000;28(2):355–63. doi:10.1016/S0896-6273(00)00115-X. PMID 11144346.
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed., text revision (DSM-IV-TR). 2000. ISBN 0890420254. Diagnostic criteria for 299.80 Asperger's Disorder (AD).
- National Institute of Mental Health. Autism spectrum disorders (pervasive developmental disorders); 2009 [Retrieved 2009-04-23].
- Freitag CM. The genetics of autistic disorders and its clinical relevance: a review of the literature. Mol Psychiatry. 2007;12(1):2–22. doi:10.1038/sj.mp.4001896. PMID 17033636.
- Piven J, Palmer P, Jacobi D, Childress D, Arndt S. Broader autism phenotype: evidence from a family history study of multiple-incidence autism families [PDF]. Am J Psychiatry. 1997;154(2):185–90. PMID 9016266.
- Klin A. Autism and Asperger syndrome: an overview. Rev Bras Psiquiatr. 2006;28(suppl 1):S3–S11. doi:10.1590/S1516-44462006000500002. PMID 16791390.
- Diagnostic and Statistical Manual of Mental Disorders (4th ed., text rev.). Washington, D.C.: American Psychiatric Association. 2000.
- "NINDS Asperger Syndrome Information Page". National Institute of Neurological Disorders and Stroke.
- Mesibov, G.B. (1997). "Ask the Editor: What is PDD-NOS and how is it diagnosed?". Journal of Autism and Developmental Diso 27 (4).
- Murray, Dinah; Lesser, M. & Lawson, W (1 May 2005). "Attention, monotropism and the diagnostic criteria for autism". Autism 9 (2).
- Zwaigenbaum L, Bryson S, Lord C, et al. (May 2009). "Clinical assessment and management of toddlers with suspected autism spectrum disorder: insights from studies of high-risk infants". Pediatrics 123 (5): 1383–91.
- Lord, C (1995). "Follow-up of two-year-olds referred for possible autism". Journal of Child Psychology and Psychiatry 36 (8): 1365–1382.
- Zwaigenbaum L (October 2001). "Autistic spectrum disorders in preschool children". Can Fam Physician 47 (10): 2037–42.
- Martínez-Pedraza Fde L, Carter AS (July 2009). "Autism spectrum disorders in young children". Child Adolesc Psychiatr Clin N Am 18 (3): 645–63.
- Werner, E; Dawson, Munson, & Osterling (2005). "Variation in early developmental course in autism and its relation with behavioral outcome at 3-4 years of age". Journal of Autism and Developmental Disorders 35 (3): 337–350.
- Mash & Barkley (2003). Child Psychopathology. New York: The Guilford Press. pp. 409–454.
- Mawhood, L; Howlin, & Rutter (2000). "Autism and developmental receptive language disorder: A comparative follow-up in early adult life. I. Cognitive and language outcomes". Journal of Child Psychology and Psychiatry 41 (5): 547–559.
- Dawson & Osterling (1997). The effectiveness of early intervention. Baltimore: Brookes. pp. 307–326.
- Rutter, M (2000). "Genetic studies of autism: From the 1970s into the millennium". Journal of Abnormal Child Psychology 28 (1): 3–14.
- Szatmari, P (1999). "Heterogeneity and the genetics of autism". Journal of Psychiatry and Neuroscience 24 (2): 159–165.
- Rutter, M; Macdonald, Le Couteur, Harrington, Bolton, & Bailey (1990). "Genetic factors in child psychiatric disorders: II. Empirical findings". Journal of Child Psychology and Psychiatry 31 (1): 39–83.
- Losh M, Sullivan PF, Trembath D, Piven J (September 2008). "Current developments in the genetics of autism: from phenome to genome". J. Neuropathol. Exp. Neurol. 67 (9): 829–37.
- Freitag CM, Staal W, Klauck SM, Duketis E, Waltes R (March 2010). "Genetics of autistic disorders: review and clinical implications". Eur Child Adolesc Psychiatry 19 (3): 169–78.
- Chaste P, Leboyer M (September 2012). "Autism risk factors: genes, environment, and gene-environment interactions". Dialogues Clin Neurosci 14 (3): 281–92.
- O'Brien, G; Pearson (2004). "Autism and learning disability". Autism 8 (2): 125–140.
- Gardner, H; Spiegelman, & Buka (2011). "Perinatal and Neonatal Risk Factors for Autism: A Comprehensive Meta-analysis". Pediatrics 128 (2): 344–355.
- Flaherty, DK (2011). "The vaccine-autism connection: a public health crisis caused by unethical medical practices and fraudulent science.". The Annals of pharmacotherapy 45 (10): 1302–4.
- Godlee, F; Smith, J; Marcovitch, H (2011). "Wakefield's article linking MMR vaccine and autism was fraudulent.". BMJ (Clinical research ed.) 342: c7452.
- Tan; Parkin (2008). "Route of decomposition of thimerosal". International Journal of Pharmacy 24: 13299– 13305.
- Waterhous, Lynn (2008). "Autism overflows: Increasing prevalence and proliferating theories". Neuropsychological Review 18 (4): 273–286.
- Taylor LE, Swerdfeger AL, Eslick GD. Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies. Vaccine. 2014;32(29):3623–9. doi:10.1016/j.vaccine.2014.04.085. PMID 24814559. Lay summary: news.com.au.
- Koenig, Kathleen; Tsatsanis, Katherine D.; Volkmar, Fred R. (2001). Jacob A Burack, Tony Charman, Nurit Yirmiya, Philip R. Zelazo, ed. Neurobiology and Genetics ofd Autism : A Developmental Perspective. The development of autism : perspectives from theory and research (Mahwah, N.J.: L. Erlbaum,). pp. 73–92.
- Minshew, NJ (1996). "Brief report: Brain mechanisms in autism: Functional and structural abnormalities". Journal of Autism and Developmental Disorders 26 (2): 205–209.
- Sugranyes G, Kyriakopoulos M, Corrigall R, Taylor E, Frangou S (2011). "Autism spectrum disorders and schizophrenia: meta-analysis of the neural correlates of social cognition". PLoS ONE 6 (10): e25322.
- Fadiga, L.; Craighero, L. & Olivier, E. (2005). "Human motor cortex excitability during the perception of others' action". Current Opinion in Neurobiology 15 (2): 213–218.
- Shamay-Tsoory, S.G. (2011). "The Neural Bases for Empathy". The Neuroscientist 17 (1): 18–24.
- Nishitani, N.; Avikainen S. & Hari R. (2004). "Abnormal imitation-related cortical activation sequences in Asperger's syndrome". Annals of Neurology 55 (4): 558–562.
- Dapretto, M., Davies M.S. et al. (2006). "Understanding emotions in others: mirror neuron dysfunction in children with autism spectrum disorders". Nature Neuroscience 9 (1): 28–30.
- Dinstein I, Thomas C, Behrmann M, Heeger DJ (2008). "A mirror up to nature". Curr Biol 18 (1): R13–8.
- Schultz, R. (2005). "Developmental deficits in social perception in autism: The role of amygdala and fusiform face area". International Journal of Developmental Neuroscience 23 (2–3): 125–141.
- Xue Ming, Brimacombe M, Chaaban J, Zimmerman-Bier B, Wagner GC (2008). "Autism spectrum disorders: concurrent clinical disorders". J Child Neurol 23 (1): 6–13.
- Haas RH, Parikh S, Falk MJ, Saneto RP, Wolf NI, Darin N, Cohen BH (2007). "Mitochondrial disease: a practical approach for primary care physicians". Pediatrics 120 (6): 1326–1333.
- Oliveira G, Diogo L, Grazina M, Garcia P, Ataíde A, Marquess C, Miguel T, Borges L, Vicente AM, Oliveira CR (2005). "Mitochondrial dysfunction in autism spectrum disorders: a population-based study". Dev Med Child Neurol 47 (3): 185–189.
- "Autism Spectrum Disorder (ASD): Screening and Diagnosis". Centers for Disease Control and Prevention.
- Lord, C; Risi, S; DiLavore, PS; Shulman, C; Thurm, A; Pickles, A (Jun 2006). "Autism from 2 to 9 years of age.". Archives of General Psychiatry 63 (6): 694–701.
- Volkmar F, Cook EH, Pomeroy J, Realmuto G, Tanguay P (December 1999). "Practice parameters for the assessment and treatment of children, adolescents, and adults with autism and other pervasive developmental disorders. American Academy of Child and Adolescent Psychiatry Working Group on Quality Issues". J Am Acad Child Adolesc Psychiatry 38 (12 Suppl): 32S–54S.
- Uekermann J, Daum I (May 2008). "Social cognition in alcoholism: a link to prefrontal cortex dysfunction?". Addiction 103 (5): 726–35.
- Filipek PA, Accardo PJ, Ashwal S, et al. (August 2000). "Practice parameter: screening and diagnosis of autism: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society". Neurology 55 (4): 468–79.
- Filipek PA, Accardo PJ, Baranek GT, et al. (December 1999). "The screening and diagnosis of autistic spectrum disorders". J Autism Dev Disord 29 (6): 439–84.
- Ozonoff, S.; Goodlin-Jones, B.L. & Solomon, M. (2005). "Evidence-Based Assessment of Autism". Journal of Clinical and Child Adolescent Psychology 34 (3): 523–540.
- Corsello C, Hus V, Pickles A, et al. (September 2007). "Between a ROC and a hard place: decision making and making decisions about using the SCQ". J Child Psychol Psychiatry 48 (9): 932–40.
- Huerta M, Lord C (February 2012). "Diagnostic evaluation of autism spectrum disorders". Pediatr. Clin. North Am. 59 (1): 103–11, xi.
- Helverschou,, S.B.; Bakken, T.L.; Martinsen., H. (2011). Johnny L Matson; Peter Sturmey, ed. Psychiatric Disorders in People with Autism Spectrum Disorders: Phenomenology and Recognition. International handbook of autism and pervasive developmental disorders (New York: Springer,). pp. 53–74.
- Underwood L, McCarthy J, Tsakanikos E (September 2010). "Mental health of adults with autism spectrum disorders and intellectual disability". Current Opinion in Psychiatry 23 (5): 421–6.
- Ballaban-Gil, K; Tuchman (2000). "Epilepsy and epileptiform EEG: Association with autism and language disorders". Mental Retardation and Developmental Disabilities Research Reviews 6 (4): 300–308.
- Wiznitzer, M (2004). "Autism and tuberous sclerosis". Journal of Child Neurology 19 (9): 675–679.
- Lainhart, J (1999). "Psychiatric problems in individuals with autism, their parents and siblings". International Review of Psychiatry 11 (4): 278–298.
- Tsakanikos E, Costello H, Holt G, Sturmey P, Bouras N (July 2007). "Behaviour management problems as predictors of psychotropic medication and use of psychiatric services in adults with autism". J Autism Dev Disord 37 (6): 1080–5.
- Rommelse, NN; Franke, Geurts, Hartman, & Buitelaar (2010). "Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder". European Child and Adolescent Psychiatry 19 (3): 281–295.
- Baranek, G (2002). "Efficacy of sensory and motor interventions in children with autism". Journal of Autism and Developmental Disorders 32 (5): 397–422.
- Myers SM, Johnson CP, Council on Children with Disabilities. Management of children with autism spectrum disorders. Pediatrics. 2007;120(5):1162–82. doi:10.1542/peds.2007-2362. PMID 17967921. Lay summary: AAP, 2007-10-29.
- Rogers SJ, Vismara LA (January 2008). "Evidence-based comprehensive treatments for early autism". J Clin Child Adolesc Psychol 37 (1): 8–38.
- Newschaffer CJ, Croen LA, Daniels J, et al. (2007). "The epidemiology of autism spectrum disorders". Annu Rev Public Health 28: 235–58.
- Fombonne, E (2009). "Epidemiology of Pervasive Developmental Disorders". Pediatric Research 65 (6): 591–598.
- (ADDM) Autism and Developmental Disabilities Monitoring Network Surveillance Year 2006 Principal Investigators (2009). "Prevalence of autism spectrum disorders-Autism and Developmental Disabilities Monitoring Network". MMWR Surveillance Summary 58: 1–20.
- Volkmar, F; Lord, Bailey, Schultz, & Klin (2004). "Autism and pervasive developmental disorders". Journal of Child Psychology and Psychiatry 45 (1): 135–170.
- Tsakanikos, Elias; Underwood, Lisa; Kravariti, Eugenia; Bouras, Nick; McCarthy, Jane (2011). "Gender differences in co-morbid psychopathology and clinical management in adults with autism spectrum disorders". Research in Autism Spectrum Disorders 5 (2): 803–808.
- Kanner, L (1949). "Problems of nosology and psychodynamics in early childhood autism".
- Solomon, Andrew (2008-05-25). "The autism rights movement". New York. Archived from the original on 27 May 2008. Retrieved 2008-05-27.
- Mission Statement. Autism Acceptance Project. Retrieved on 2008-11-24.
- Mission Statement. Aspies for Freedom. Retrieved on 2008-11-24.
- Autism Network International presents Autreat. (2008-05-23) AIN.
- "Declaration From the Autism Community That They Are a Minority Group" (Press release). PRWeb, Press Release Newswire. 2004-11-18. Retrieved 2007-11-07.
- "The autism rights movement". Synapse.org.au.
- Amy Sequenzia (2013-01-19). "When Autistics Grade Other Autistics". Ollibean.
- Autism spectrum at DMOZ